138 related articles for article (PubMed ID: 19232027)
1. Psychopharmacology news.
Silva R
J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):91. PubMed ID: 19232027
[No Abstract] [Full Text] [Related]
2. Antiaggressive action of combined risperidone and quetiapine in a patient with schizophrenia.
Bozikas VP; Deseri C; Pitsavas S; Karavatos A
Can J Psychiatry; 2003 Jul; 48(6):426-7. PubMed ID: 12894620
[No Abstract] [Full Text] [Related]
3. The CATIE schizophrenia effectiveness trial.
Delisi LE; Nasrallah HA
Schizophr Res; 2005 Dec; 80(1):v-vi. PubMed ID: 16291292
[No Abstract] [Full Text] [Related]
4. FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.
Kuehn BM
JAMA; 2009 Aug; 302(8):833-4. PubMed ID: 19706851
[No Abstract] [Full Text] [Related]
5. Psychopharmacology update: why choose quetiapine for bipolar illness?
Tobin ML
Issues Ment Health Nurs; 2007 Apr; 28(4):437-9. PubMed ID: 17454294
[No Abstract] [Full Text] [Related]
6. Validity of conclusions about quetiapine.
McIntyre RS
Am J Health Syst Pharm; 2008 Jan; 65(2):114-5; author reply 115-6. PubMed ID: 18192252
[No Abstract] [Full Text] [Related]
7. Adjunctive antipsychotics for major depression.
Med Lett Drugs Ther; 2011 Sep; 53(1373):74-5. PubMed ID: 21921872
[No Abstract] [Full Text] [Related]
8. Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression.
Galynker I; Khan A; Grebchenko Y; Ten A; Malaya L; Yanowitch P; Cohen LJ
J Clin Psychiatry; 2005 Apr; 66(4):544. PubMed ID: 15816805
[No Abstract] [Full Text] [Related]
9. Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER).
Naber D; Peuskens J; Schwarzmann N; Goltz M; Krüger H; Lambert M; Haro JM
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1257-69. PubMed ID: 23953270
[TBL] [Abstract][Full Text] [Related]
10. Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder.
Rakofsky JJ; Dunlop BW; Beyer JL; Oliver AM; Mansson EE; Sancheti MT; Harvey PD
J Clin Psychopharmacol; 2014 Jun; 34(3):383-5. PubMed ID: 24717252
[No Abstract] [Full Text] [Related]
11. Quetiapine treatment for mania secondary to brain injury in 2 patients.
Daniels JP; Felde A
J Clin Psychiatry; 2008 Mar; 69(3):497-8. PubMed ID: 18402501
[No Abstract] [Full Text] [Related]
12. Risperidone and clozapine for treatment-resistant schizophrenia.
Dunayevich E; Chatterjee A
Am J Psychiatry; 1999 Jul; 156(7):1127; author reply 1127-8. PubMed ID: 10401486
[No Abstract] [Full Text] [Related]
13. FDA panel issues mixed decision on quetiapine in depression and anxiety.
Kuehn BM
JAMA; 2009 May; 301(20):2081-2. PubMed ID: 19470978
[No Abstract] [Full Text] [Related]
14. Antipsychotic choices now include quetiapine.
Am J Health Syst Pharm; 1997 Nov; 54(22):2547. PubMed ID: 9397210
[No Abstract] [Full Text] [Related]
15. A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia.
Gharabawi GM; Bossie CA; Pandina GJ; Kujawa MJ; Greenspan AJ; Zhu Y
J Clin Psychiatry; 2007 Feb; 68(2):333; author reply 334. PubMed ID: 17335334
[No Abstract] [Full Text] [Related]
16. Eficcacy of extended release quetiapine in affective symptoms.
Alamo C; López-Muñoz F
Rev Psiquiatr Salud Ment; 2012; 5 Suppl 1():3-19. PubMed ID: 23265762
[No Abstract] [Full Text] [Related]
17. Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidone.
Kasper S; Montagnani G; Trespi G; Di Fiorino M
Int Clin Psychopharmacol; 2015 Jan; 30(1):14-22. PubMed ID: 25356632
[TBL] [Abstract][Full Text] [Related]
18. Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis.
Locklear JC; Wahlqvist P; Gustafsson U; Udd M; Fajutrao L; Eriksson H
J Comp Eff Res; 2014 Jul; 3(4):335-44. PubMed ID: 25275231
[TBL] [Abstract][Full Text] [Related]
19. Cataracts and quetiapine.
Valibhai F; Phan NB; Still DJ; True J
Am J Psychiatry; 2001 Jun; 158(6):966. PubMed ID: 11384916
[No Abstract] [Full Text] [Related]
20. Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.
Locklear JC; Alemayehu B; Brody RS; Chavoshi S; Tunceli O; Kern D; Earley WR
Clin Ther; 2013 Dec; 35(12):1923-32. PubMed ID: 24275622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
